TABLE II.

Significant EEG Spectral Power Changes in ALS Patients Compared to the Healthy Control Group

EEG CH.	Freq. Band	Healthy Averaged Power±STD (µV2)	ALS Averaged Power±STD (µV2)	p-value
F2	Theta	2.91±0.43	2.16±0.38	0.004
Fz	Theta	2.93±0.38	2.37±0.34	0.02
T7	Theta	2.23±0.85	1.61±0.6	0.007
T8	Theta	2.01±0.91	1.13±0.84	0.006
Cz	Theta	2.71±0.56	2.25±0.36	0.03
Fz	Alpha	4.13±0.37	2.67±0.72	0.01
T7	Alpha	3.42±0.73	1.81±0.52	<0.001
T8	Alpha	3.21±0.77	1.42±0.83	0.005
Cz	Alpha	4.44±0.82	3.18±0.72	0.008
P7	Alpha	4.56±0.82	2.53±0.58	0.03
P3	Alpha	5.63±0.84	3.37±0.42	0.004
Pz	Alpha	6.23±1.12	3.84±0.52	0.005
P4	Alpha	5.71±1.12	3.36±0.81	0.02
P8	Alpha	5.4±0.94	2.92±0.57	0.01
PO7	Alpha	5.61±0.72	2.94±0.75	0.006
PO8	Alpha	5.84±0.91	3.02±0.75	0.005
Oz	Alpha	4.43±0.76	2.23±0.72	<0.001